<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00814151</url>
  </required_header>
  <id_info>
    <org_study_id>MP-2008B</org_study_id>
    <nct_id>NCT00814151</nct_id>
  </id_info>
  <brief_title>MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial</brief_title>
  <official_title>Primary Investigation Into the Performance of the MicroPhage S. Aureus / MSSA / MRSA Test Direct From Blood Culture.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroPhage, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroPhage, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In-vitro identification of S. aureus, methicillin-sensitive S. aureus (MSSA), and
      methicillin-resistant S. aureus (MRSA) from positive blood cultures by MicroPhage's
      bacteriophage-based diagnostic platform.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, preclinical study to investigate the effectiveness of the performance
      of MicroPhage S. aureus / MSSA/MRSA test direct for blood culture. There will be no patient
      consent, as this is a laboratory performance study on leftover specimens. The MicroPhage test
      will be compared to site standards (gold standard) and market-available tests with similar
      indications (comparators). MicroPhage will require data to be collected at 4 hours and 5
      hours following the start of the MicroPhage test. The study will last 2-3 months, depending
      on the accrual rate of the institution.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of clinical performance of preliminary MicroPhage S. aureus/MSSA/MRSA test directly from clinical blood culture positives.</measure>
    <time_frame>Within 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative feedback on the preliminary MicroPhage test protocol.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparative results to market-available S. aureus / MRSA tests for Blood Culture.</measure>
    <time_frame>Within 48 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">712</enrollment>
  <condition>Bacteremia</condition>
  <condition>Staphylococcal Infection</condition>
  <condition>Sepsis</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>MicroPhage</arm_group_label>
    <description>Blood Culture positive specimens available within 24 hours of alarm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <description>Blood Culture positive specimens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MicroPhage S. aureus / MSSA / MRSA Blood Culture Test (prototype)</intervention_name>
    <description>In vitro diagnostic: The MicroPhage &quot;Intervention&quot; was to perform the MicroPhage diagnostic test to detect S. aureus in the blood culture sample and determine MSSA or MRSA status at 4 and 5 hours of test incubation. The &quot;Intervention&quot; results were not made available to the patient or their physician.</description>
    <arm_group_label>MicroPhage</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Retention of discrepant blood culture specimens only.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Blood culture positive specimens from three academic medical centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age.

          -  Blood culture positive, of ANY of the following bottle types:

          -  BD Bactec Standard Aerobic and Anaerobic,

          -  BD Bactec Plus Aerobic and Anaerobic,

          -  bioMerieux BacT/Alert Standard Aerobic and Anaerobic,

          -  bioMerieux BacT/Alert FAN Aerobic and Anaerobic.

        Exclusion Criteria:

          -  BD Bactec Lytic, Pediatric, or other bottle types not listed above.

          -  bioMerieux Pediatric FAN or other bottle types listed above.

          -  Trek bottles.

          -  Specimens from patients under 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J D Smith, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MicroPhage, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Evanston Northwestern Healthcare Research Institute</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Medical Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2008</study_first_submitted>
  <study_first_submitted_qc>December 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2008</study_first_posted>
  <last_update_submitted>December 23, 2008</last_update_submitted>
  <last_update_submitted_qc>December 23, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2008</last_update_posted>
  <responsible_party>
    <name_title>Scott Conlin</name_title>
    <organization>MicroPhage, Inc.</organization>
  </responsible_party>
  <keyword>Blood culture</keyword>
  <keyword>Staphylococcus aureus</keyword>
  <keyword>Bacteremia</keyword>
  <keyword>MRSA</keyword>
  <keyword>MSSA</keyword>
  <keyword>MicroPhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

